For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.
Matt Hewitt
Advertisement
Matt Hewitt is executive director, Scientific Services Cell and Gene Therapy at Charles River.
Articles by Matt Hewitt
Advertisement
Latest Updated Articles
The Road to Personalized Medicine: Reimagining Drug ManufacturingPublished: September 15th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
